Shire

Showing 15 posts of 170 posts found.

Shire image

Shire delivers record revenues

February 16, 2015
Sales and Marketing ADHD, AbbVie, Shire, Viropharma, Vyvanse, intuniv, lialda

Shire has posted strong growth in its full-year results, showing that the company is faring well even after the collapse …

edward_bliss

MRC Technology hires senior head from Shire

February 11, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Edward Bliss, MRC, Shire

UK medical research charity MRC Technology has appointed Dr Edward Bliss to the new role of general counsel and company …

Shire image

Shire drug approved for binge eating disorder

February 2, 2015
Sales and Marketing ADHD, FDA, Shire, Vyvanse, binge, eating, lisdexamfetamine dimesylate, obesity

Shire has become the first company to gain FDA approval for a treatment for binge eating disorder (BED) in adults …

Shire image

Shire lifted by rare disease approvals

January 26, 2015
Sales and Marketing HGT-2310, Hunter syndrome, SHP609, Shire, fast track, idursulfase-IT, rare disease

Shire’s investigational drug for a rare neurological disease has been accepted into the FDA’s fast-track approval process. The drug, SHP609, …

Shire image

Shire buys rare-disease firm NPS Pharma

January 12, 2015
Sales and Marketing AbbVie, Shire, gattex, natpara, nps, nps pharma

Shire is to acquire rare diseases firm NPS Pharma to enhance its profile following the collapse of its deal with …

PM Society names pharma prize finalists

December 17, 2014
Medical Communications, Sales and Marketing GSK, Mundipharma, Shire, VCCP Health, digital awards, pm society

The finalists for the PM Society Awards have been announced today as pharma and med comms agencies gear up to …

Mark Rus image

Working Life: Shire’s Mark Rus

November 10, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Shire, Working Life, mark rus, neuroscience

How did you find your way into your current role? After completing an MSc in Economics at the London School …

james_bowling

Shire interim chief financial officer resigns

October 21, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Shire, james bowling, merger

Shire’s interim chief financial officer James Bowling has left the firm for water company Severn Trent following the collapse of …

shire_image_1

AbbVie ditches Shire as tax deal falters

October 21, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Obama, Shire, US government, tax, tax inversion

Tax rule changes coming from the US government have forced the collapse of a multi-billion dollar deal between Humira manufacturer …

Abbvie image

AbbVie reconsiders Shire deal over tax laws

October 15, 2014
Medical Communications, Sales and Marketing AbbVie, Abbott, Obama, Shire, US, mergers, tax

AbbVie will reconsider its planned $54.6 billion takeover of Shire in light of new US proposals designed to curb companies …

Shire image

Shire accused of dishonest marketing in US

September 25, 2014
Medical Communications, Sales and Marketing Adderall XR, Department of Justice, DoJ, Shire, US, amphetamine, dextroamphetamine

Shire will pay a fine of $56.5 million to resolve a string of legal allegations in the US surrounding the …

Shire logo

AbbVie/Shire deal under threat from tax laws

August 7, 2014
Medical Communications, Sales and Marketing AbbVie, AstraZeneca, Pfizer, Shire, tax inversion

The £32 billion deal between AbbVie and Irish specialist biotech Shire could be under threat from new rules in the …

Shire image

AbbVie agrees to buy Shire for £32bn

July 18, 2014
Sales and Marketing AbbVie, Abbott, Humira, Shire, merger, new abbvie, takeover

Shire has accepted a £32 billion takeover deal from AbbVie after months of rejections and uncertainty. The firm, which is …

abbvie image

AbbVie a step closer to Shire takeover

July 14, 2014
Sales and Marketing ADHD, AbbVie, Abbott, Humira, Shire, hep C, takeover

Shire is recommending a new offer from suitor AbbVie that could finally see the US giant merge with the Dublin-based …

Shire image

AbbVie makes fourth Shire offer

July 9, 2014
Sales and Marketing AbbVie, Abbott, Shire, buyout, merger

The AbbVie/Shire takeover saga rumbles on, with AbbVie raising its bid for the Ireland-based biopharma specialist to $51.5 billion. The …

The Gateway to Local Adoption Series

Latest content